[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-353736-105":59,"doc-detail-353736-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","decoding-the-tumor-microenvironment-remodeling-orchestrated-by-clec3b-inflammatory-cancer-associated-fibroblasts-in-lung-adenocarcinoma-immunotherapy-elucidation-from-pan-cancer-spatially-single-cell-transcriptomics-landscape","Decoding the tumor microenvironment remodeling orchestrated by CLEC3B+ inflammatory cancer-associated fibroblasts in lung adenocarcinoma immunotherapy: elucidation from pan-cancer spatially single-cell transcriptomics landscape","","Pan-cancer inflammatory cancer-associated fibroblasts (iCAFs) and their spatial organization are evaluated for explaining variability in immune checkpoint inhibitor (ICI) responses. Using pan-cancer single-cell and spatial transcriptomics analyses, the study focuses on CLEC3B+ iCAFs and derives an Inflammatory CAF Signature (ICS) that integrates iCAF marker genes with machine learning. Comprehensive single-cell and validation experiments test how CLEC3B+ iCAFs alter TME interactions and ICI efficacy, highlighting cellular communication, cell-to-cell distances, and mechanisms tied to the JAK2–STAT3 axis.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/decoding-the-tumor-microenvironment-remodeling-orchestrated-by-clec3b-inflammatory-cancer-associated-fibroblasts-in-lung-adenocarcinoma-immunotherapy-elucidation-from-pan-cancer-spatially-single-cell-transcriptomics-landscape/353736/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/decoding-the-tumor-microenvironment-remodeling-orchestrated-by-clec3b-inflammatory-cancer-associated-fibroblasts-in-lung-adenocarcinoma-immunotherapy-elucidation-from-pan-cancer-spatially-single-cell-transcriptomics-landscape/353736.png","ImageObject",300,407,{"name":92,"@type":93},"Theodore","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-09","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",13,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What is the main objective of this study?","Question",{"text":113,"@type":114},"To decode how CLEC3B+ inflammatory cancer-associated fibroblasts remodel the tumor microenvironment and influence ICI efficacy in lung adenocarcinoma and across cancers.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How is the Inflammatory CAF Signature (ICS) constructed?",{"text":118,"@type":114},"The study integrates pan-cancer single-cell and RNA-seq data to build the ICS using iCAF marker genes and machine learning to predict ICI response.",{"name":120,"@type":111,"acceptedAnswer":121},"What biological factors link CLEC3B+ iCAFs to ICI response?",{"text":122,"@type":114},"Cellular communication and spatial relationships, including cell-to-cell distances between iCAFs and CD8+ Tex cells, are shown to affect ICI efficacy, alongside pathway activity tied to CLEC3B-driven signaling.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},353736,1790194064,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},7971461740886,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","Li et al. Journal of Translational Medicine (2026) 24:275  \n[https://doi.org/10.1186/s12967-026-07677-2](https://doi.org/10.1186/s12967-026-07677-2)  \nJournal of Translational Medicine  \nRESEARCH Open Access  \nDecoding the tumor microenvironment  remodeling orchestrated by CLEC3B+ inflammatory cancer-associated fibroblastsin lung adenocarcinoma immunotherapy:  \nelucidation from pan-cancer spatially singlecell transcriptomics landscape  \nShan Li 1,2†, Kangqiang Weng3†, Leye Yan4†, Yingying Lu 1, Ran Zhou 1, Zongming Fan5, Zhongxin Yang 1, Jian Yue6* and Wei Li 1*  \nAbstract  \nIntroduction The heterogeneity of cancer-associated fibroblasts (CAFs) would possibly influence reaction to immune checkpoint inhibitor (ICI) therapy. However, limited researches investigated inflammatory CAFs (iCAFs) in ICI therapy using pan-cancer single-cell RNA sequencing (scRNA-seq) and spatial transcriptomics RNA sequencing (stRNA-seq) analysis.  \nMethods We performed pan-cancer scRNA-seq and stRNA-seq analyses to investigate CLEC3B+ iCAFs, exploring its spatial distribution characteristics. The pan-cancer scRNA-seq and RNA-seq data are incorporated to develop the Inflammatory CAF Signature (ICS), which predicts ICI response based on iCAF marker genes and machine learning techniques. Comprehensive scRNA-seq analysis, with in vivo and in vitro experiments, investigates the mechanisms by which CLEC3B+ iCAFs influence ICI efficacy.  \nResults The ICS model performs well in predicting ICI response in pan-cancer patients. A higher proportion of total iCAFs is observed in ICI non-responders in pan-cancer landscape and lung adenocarcinoma (LUAD) . Cellular communication and stRNA-seq analyses confirm that intercellular interactions and cell-to-cell distances between iCAFs and CD8+ Tex cells impact ICI efficacy. A critical functional heterogeneity within iCAFs modulated by CLEC3B is  \n†Shan Li, Kangqiang Weng and Leye Yan contributed equally to this work and share first authorship.  \n*Correspondence: Jian Yue [tamoxifen@126.com](tamoxifen@126.com)[ ](tamoxifen@126.com)Wei Li[jnsqs1018@sina.com](jnsqs1018@sina.com)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/l](vecommons.org/l)icenses/by-nc-nd/4.0/.  \nLi et al. Journal of Translational Medicine (2026) 24:275 Page 2 of 28  \nrevealed, while functional experiments confirm that downregulation of CLEC3B on CAFs drives CD8+ T cells toward a dysfunctional state in LUAD. CLEC3B activates JAK2–STAT3 pathway by inhibiting SOCS3 deubiquitylation, enhancing the immunostimulatory effects of CAFs. In a subcutaneously tumor grafted mouse model, combining CLEC3Boverexpression with ICI treatment achieves optimal efficacy in LUAD.  \nConclusion Our study provides ICS model as an outperforming approach for patient selection of ICI, and advances our understanding of CAF biology and suggests potential therapeutic strategies for upregulating CLEC3B in CAFs in cancer immunotherapy.  \n","cbCaiio6Ys7a0o2c","https://ap.wps.com/l/cbCaiio6Ys7a0o2c","pdf",17734736,28,"English","# Abstract\n# Introduction\n# Methods\n# Results\n# Conclusion\n# Keywords","[{\"question\":\"What is the main objective of this study?\",\"answer\":\"To decode how CLEC3B+ inflammatory cancer-associated fibroblasts remodel the tumor microenvironment and influence ICI efficacy in lung adenocarcinoma and across cancers.\"},{\"question\":\"How is the Inflammatory CAF Signature (ICS) constructed?\",\"answer\":\"The study integrates pan-cancer single-cell and RNA-seq data to build the ICS using iCAF marker genes and machine learning to predict ICI response.\"},{\"question\":\"What biological factors link CLEC3B+ iCAFs to ICI response?\",\"answer\":\"Cellular communication and spatial relationships, including cell-to-cell distances between iCAFs and CD8+ Tex cells, are shown to affect ICI efficacy, alongside pathway activity tied to CLEC3B-driven signaling.\"}]","Decoding the tumor microenvironment remodeling orchestrated by CLEC3B+ inflammatory cancer-associated fibroblasts in lung adenocarcinoma immunotherapy: elucidation from pan-cancer spatially single-cell transcriptomics landscape | PDF",1790107004,71,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9c9fb9dc073b395d79e51563a652491e.webp",983,1310,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/14563f34ef7e23e0d7f7a5a7161b41da.webp",982,1309,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c93a03078be90605b82ab32724ac2dc7.webp",981,1308,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/120e5c9b8935c2cf98310bff40637e65.webp",980,1306]